SUD & Addiction Billing for Hawaii Treatment Centers

Hawaii's addiction-treatment landscape is smaller and more concentrated than the mainland's, but the billing is no less demanding — and because capacity is tight, every collected dollar matters more. We bill the full continuum for programs on Oahu, Maui, Hawaii Island, and Kauai:

We serve programs from Honolulu and the greater Oahu communities to Hilo and Kona on Hawaii Island, Kahului and West Maui, and Lihue on Kauai — each billed to its Med-QUEST plan and to the commercial payers behind its private-pay census, statewide.

Most Hawaii Medicaid members receive their SUD benefit through Med-QUEST, the state's managed-care program, while the Alcohol and Drug Abuse Division (ADAD) of the Department of Health sets the state's SUD service framework, provider standards, and grant-funded slots. That means a residential or outpatient admission answers to a Med-QUEST plan's authorization rules and to ADAD's clinical expectations at the same time — and a claim built as if it were a straight commercial rehab claim will misroute from the start.

Geography then reshapes everything. Bed supply is limited, so a client on a neighbor island may receive detox locally, step down to a telehealth-supported outpatient program, and — when the islands cannot supply the needed level of care — travel to an out-of-state residential facility. Each of those transitions is a billing event with its own payer, authorization, and place-of-service implications, and out-of-network reimbursement, single-case agreements, and appeals become central whenever care crosses to the mainland. Telehealth-delivered IOP and counseling add place-of-service and modifier requirements that vary by payer. A program can deliver excellent care across three islands and still lose revenue if the claims do not follow the client cleanly through each step.

Utilization review is relentless here as everywhere. Every commercial and Med-QUEST payer wants an ASAM-justified reason for the level of care on admission and an ASAM-justified reason for each continued day, and a missed or late concurrent review is the most preventable denial an addiction program faces. Because Medicare plays only a limited role in addiction treatment — the Noridian (JE) MAC footprint matters mainly for the occasional covered service and dually eligible clients — most Hawaii SUD revenue moves through Med-QUEST and commercial payers. And SUD records carry 42 CFR Part 2 federal confidentiality on top of HIPAA, changing how release-of-information and coordination-of-benefits are handled — a constraint a generalist rarely respects until an audit exposes it.

Medication-assisted treatment deserves particular attention in Hawaii, where geography can put the nearest opioid treatment program hours and a ferry or flight away. Office-based buprenorphine practices in rural and neighbor-island communities have become a lifeline, and their billing runs on evaluation-and-management plus medication management rather than the weekly bundled payment an OTP submits. Extended-release naltrexone adds its own drug-and-administration logic. When these MAT pathways are coded as if they were ordinary outpatient visits, revenue leaks quietly and audit exposure grows — so we bill each one to its own rules. Drug testing carries the same care: presumptive versus definitive urine testing is the most audited, most recouped area in SUD billing, and we document ordering rationale and code to payer limits so testing revenue holds up under review rather than becoming a recoupment target.

Hawaii addiction programs choose us because we already speak Med-QUEST managed care, ADAD standards, out-of-network and out-of-state placement, and cross-island telehealth in the same breath. We bill the entire ASAM continuum and reconcile every unit and per-diem day to the documentation a Hawaii utilization reviewer will actually open. Our metrics are the ones that survive scrutiny: first-pass clean-claim rates near 99%, up to 40% fewer denials once level-of-care and UR workflows are fixed, roughly 90% of worked denials recovered, days in A/R held under 25, and 98% client retention across the programs we serve.

Stop leaving continued-stay days, telehealth sessions, and out-of-state claims on the table. Let a team that lives in Med-QUEST managed care, ASAM utilization review, and out-of-network reimbursement work your book.

Written by Danny Johnsmith and Kris Pat. Reviewed for revenue-cycle accuracy by 247MBS certified coders.